The U.S. Court dismissed the Celltrion’s claim to nullify the patent of Ramicade
The U.S. Court dismissed the patent nullity action for the rheumatoid arthritis treatment ‘Remicade’, which was filed by Celltrion.
According to the industry concerned on the 7th, the U.S. court made a judgment to dismiss the Celltrion’s DJ action claim to nullify the patent of the Janssen’s Rem...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
